A new daily pill may help people with obesity lose a significant amount of weight without the need for injections. The ...

Gov. Josh Stein urged lawmakers to pass more funding for Medicaid as cuts are expected to go into place on Oct. 1.

The FDA re-approved Wellcovorin, a drug from GSK, that the company stopped selling more than 25 years ago, as part of a push from the Trump administration to identify the causes of and potential ...

Serena Williams’ candid reaction to a cotton display went viral, dividing fans and fueling a fiery online discussion.

Recently, a different weight loss drug, ecnoglutide, with an active ingredient of the peptide ecnoglutide, has been utilized ...

Medicare Part D coverage of glucagon-like peptide-1 receptor agonists— widely prescribed for diabetes and increasingly sought for obesity and related conditions— has remained broad. A research letter ...

The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus ...

"Serena Williams stuns with a dramatic new look at Milan Fashion Week. Fans can't believe the transformation! 😲 ...

A new oral weight loss medication, orforglipron, demonstrated meaningful weight loss results in phase 3 trials, potentially ...

A new WTW survey reveals that over half of employers exceeded their healthcare budgets in 2024 and expect rising costs to continue, prompting a shift toward cost-containment strategies, vendor ...

New research from the Cleveland Clinic may explain why some people experience significant weight loss with GLP-1 medications.

I N recent months makers of weight-loss drugs have gone on a crash diet. In late July Novo Nordisk, the Danish firm that gave ...